GlassScriptPhysician profile
Michael T Bollinger
NPI 1417941642
$2,076.22
in general payments reported to CMS, 2019-2025
15 companies · $239 in 2025
The $239 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $63.25 · 2021: $1,073 · 2022: $70.50 · 2023: $179 · 2024: $88.87 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $981.91 | 2021 | |
| Stryker Corporation | $516.75 | 2019-2025 | Insignia, Triathlon, Gamma |
| Evolution Surgical, INC | $143.13 | 2019-2025 | |
| Novo Nordisk INC | $80.75 | 2022-2023 | Ozempic, Rybelsus, Wegovy |
| Bioventus LLC | $71.44 | 2019-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $68.40 | 2021-2023 | Stravix |
| Zimmer Biomet Holdings, INC. | $45.34 | 2025 | Comprehensive Shoulder System |
| Encore Medical, LP | $39.95 | 2019 | |
| Butterfly Network, INC. | $20.71 | 2022 | |
| Depuy Synthes Sales INC. | $20.19 | 2025 | Monovisc |
| Axogen | $19.35 | 2021 | |
| Ethicon US, LLC | $19.09 | 2025 | Stratafix |
| Lifenet Health | $19.05 | 2023 | |
| Glaxosmithkline, LLC. | $17.22 | 2023 | Arexvy, Shingrix |
| Fx Shoulder Solutions, INC | $12.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bollinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.